Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 3, 2014, Pages

  Park, Heung Woo ^a,b   Dahlin, Amber ^a   Tse, Szeman ^a   Duan, Qing Ling ^a   Schuemann, Brooke ^a   Martinez, Fernando D ^c   Peters, Stephen P ^d   Szefler, Stanley J ^e   Lima, John J ^f   Kubo, Michiaki ^g   Tamari, Mayumi ^g   Tantisira, Kelan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f NEMOURS CHILDREN S CLINIC   (United States)

^g RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Asthma; child; glucocorticoid; pharmacogenomics; polymorphism

Indexed keywords

CORTICOSTEROID; LEUCINE RICH REPEAT KINASE 7; PROTEIN SERINE THREONINE KINASE; SALMETEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; B LYMPHOCYTE; CHILD; CORTICOSTEROID THERAPY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ASTHMA; CHILD; GLUCOCORTICOID; PHARMACOGENOMICS; POLYMORPHISM;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CHILD; F-BOX PROTEINS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84896716139     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.12.1042     Document Type: Article

References (63)

1. K. Bahadori, M.M. Doyle-Waters, C. Marra, L. Lynd, K. Alasaly, and J. Swiston et al. Economic burden of asthma: a systematic review BMC Pulm Med 9 2009 24
2. The Global Initiative for Asthma (GINA). The guideline for asthma management and prevention 2010. Available at: http://www.ginasthma.org/ guidelines-pocket-guide-for-asthma-management.html. Accessed January 28, 2013.
3. The National Asthma Education and Prevention Program (NAEPP). National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma 2007. Available at: http://www.nhlbi.nih. gov/guidelines/asthma/asthgdln.pdf. Accessed January 28, 2013.
4. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Available at: http://www.sign.ac.uk/pdf/sign101.pdf. Accessed January 28, 2013.
5. H.A. Boushey Effects of inhaled corticosteroids on the consequences of asthma J Allergy Clin Immunol 102 Suppl 1998 S5 S16
6. K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Piñeiro, and L.X. Wei et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group Ann Intern Med 130 1999 487 495
7. S.J. Szefler, B.R. Phillips, F.D. Martinez, V.M. Chinchilli, R.F. Lemanske, and R.C. Strunk et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 115 2005 233 242
8. K.G. Tantisira, A. Damask, S.J. Szefler, B. Schuemann, A. Markezich, and J. Su et al. Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus Am J Respir Crit Care Med 185 2012 1286 1291
9. K.G. Tantisira, J. Lasky-Su, M. Harada, A. Murphy, A.A. Litonjua, and B.E. Himes et al. Genome wide association between GLCCI1 and response to glucocorticoid therapy in asthma N Engl J Med 365 2011 1173 1183
10. G.A. Hawkins, R. Lazarus, R.S. Smith, K.G. Tantisira, D.A. Meyers, and S.P. Peters et al. The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids J Allergy Clin Immunol 123 2009 1376 1383
11. E.S. Koster, A.H. Maitland-van der Zee, R. Tavendale, S. Mukhopadhyay, S.J. Vijverberg, and J.A. Raaijmakers et al. FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children Allergy 66 2011 1546 1552
12. K.G. Tantisira, E.S. Silverman, T.J. Mariani, J. Xu, B.G. Richter, and B.J. Klanderman et al. Fcer2: a pharmacogenetic basis for severe exacerbations in children with asthma J Allergy Clin Immunol 120 2007 1285 1291
13. M.J. McGeachie, A.C. Wu, H.H. Chang, J.J. Lima, S.P. Peters, and K.G. Tantisira Predicting inhaled corticosteroid response in asthma with two associated SNPs Pharmacogenomics J 13 2013 306 311
14. A.J. Rogers, K.G. Tantisira, A.L. Fuhlbrigge, A.A. Litonjua, J.A. Lasky-Su, and S.J. Szefler et al. Predictors of poor response during asthma therapy differ with definition of outcome Pharmacogenomics 10 2009 1231 1242
15. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, and W.W. Busse et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
16. J.A. Krishnan, R.F. Lemanske Jr., G.J. Canino, K.S. Elward, M. Kattan, and E.C. Matsui et al. Asthma outcomes: symptoms J Allergy Clin Immunol 129 Suppl 2012 S124 S135
17. E.B. Mougey, H. Feng, M. Castro, C.G. Irvin, and J.J. Lima Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response Pharmacogenet Genomics 19 2009 129 138
18. E.B. Mougey, C. Chen, K.G. Tantisira, K.V. Blake, S.P. Peters, and R.A. Wise et al. Pharmacogenetics of asthma controller treatment Pharmacogenomics J 13 2013 242 250
19. A.L. Fuhlbrigge, R.J. Adams, T.W. Guilbert, E. Grant, P. Lozano, and S.L. Janson et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines Am J Respir Crit Care Med 166 2002 1044 1049
20. P. Lozano, J.A. Finkelstein, J. Hecht, R. Shulruff, and K.B. Weiss Asthma medication use and disease burden in children in a primary care population Arch Pediatr Adolesc Med 157 2003 81 88
21. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods Control Clin Trials 20 1999 91 120
22. C.A. Sorkness, R.F. Lemanske Jr., D.T. Mauger, S.J. Boehmer, V.M. Chinchilli, and F.D. Martinez et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller trial J Allergy Clin Immunol 119 2007 64 72
23. R.J. Martin, S.J. Szefler, T.S. King, M. Kraft, H.A. Boushey, and V.M. Chinchilli et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial J Allergy Clin Immunol 119 2007 73 80
24. S.C. Lazarus, H.A. Boushey, J.V. Fahy, V.M. Chinchilli, R.F. Lemanske Jr., and C.A. Sorkness et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
25. R.F. Lemanske Jr., C.A. Sorkness, E.A. Mauger, S.C. Lazarus, H.A. Boushey, and J.V. Fahy et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial JAMA 285 2001 2594 2603
26. American Lung Association Asthma Clinical Research Centers, S.P. Peters, N. Anthonisen, M. Castro, J.T. Holbrook, and C.G. Irvin et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma N Engl J Med 356 2007 2027 2039
27. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender et al. PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
28. S.A. Stouffer, E.A. Suchman, L.C. DeVinney, S.A. Star, and R.M. Williams Jr. Studies in social psychology in World War II; Vol 1. The American soldier: adjustment during army life 1949 Princeton University Press Princeton (NJ)
29. G.K. Fritz, R.B. Klein, and J.C. Overholser Accuracy of symptom perception in childhood asthma J Dev Behav Pediatr 1 1990 69 72
30. J.G. Burdon, E.F. Juniper, K.J. Killian, F.E. Hargreave, and E.J. Campbell The perception of breathlessness in asthma Am Rev Respir Dis 126 1982 825 828
31. R.B. Banzett, J.A. Dempsey, D.E. O'Donnell, and M.Z. Wamboldt Symptom perception and respiratory sensation in asthma Am J Respir Crit Care Med 162 2000 1178 1182
32. H.L. Yoos, and A. McMullen Symptom perception and evaluation in childhood asthma Nurs Res 48 1999 2 8
33. S.J. Kopel, N. Walders-Abramson, E.L. McQuaid, R. Seifer, D. Koinis-Mitchell, and R.B. Klein et al. Asthma symptom perception and obesity in children Biol Psychol 84 2010 135 141
34. S.J. Szefler, and R.J. Martin Lessons learned from variation in response to therapy in clinical trials J Allergy Clin Immunol 125 2010 285 292
35. D. Nandi, P. Tahiliani, A. Kumar, and D. Chandu The ubiquitin-proteasome system J Biosci 31 2006 137 155
36. D. Skowyra, K.L. Craig, M. Tyers, S.J. Elledge, and J.W. Harper F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex Cell 91 1997 209 219
37. T. Jadhav, and M.W. Wooten Defining an embedded code for protein ubiquitination J Proteomics Bioinform 2 2009 316
38. A.L. Schwartz, and A. Ciechanover Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology Annu Rev Pharmacol Toxicol 49 2009 73 96
39. J. Zhao, J. Wei, R.K. Mialki, D.F. Mallampalli, B.B. Chen, and T. Coon et al. F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation Nat Immunol 13 2012 651 658
40. J.M. Cassavaugh, S.A. Hale, T.L. Wellman, A.K. Howe, C. Wong, and K.M. Lounsbury Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia J Cell Biochem 112 2011 3882 3890
41. R.W. Lansing, R.H. Gracely, and R.B. Banzett The multiple dimensions of dyspnea: review and hypotheses Respir Physiol Neurobiol 167 2009 53 60
42. P.J. Kolodziejski, A. Musial, J.S. Koo, and N.T. Eissa Ubiquitination of inducible nitric oxide synthase is required for its degradation Proc Natl Acad Sci U S A 99 2002 12315 12320
43. M.W. Foster, J.W. Thompson, M.T. Forrester, Y. Sha, T.J. McMahon, and D.E. Bowles et al. Proteomic analysis of the NOS2 interactome in human airway epithelial cells Nitric Oxide 34 2013 37 46
44. L.B. Bacharier, R.C. Strunk, D. Mauger, D. White, R.F. Lemanske Jr., and C.A. Sorkness Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function Am J Respir Crit Care Med 170 2004 426 432
45. C. van Dalen, E. Harding, J. Parkin, S. Cheng, N. Pearce, and J. Douwes Suitability of forced expiratory volume in 1 second/forced vital capacity vs percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents Arch Pediatr Adolesc Med 162 2008 1169 1174
46. M.R. Littner, F.W. Leung, E.D. Ballard II, B. Huang, and N.K. Samra Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms Chest 128 2005 1128 1135
47. A.C. Wu, K. Tantisira, L. Li, B. Schuemann, S.T. Weiss, and A.L. Fuhlbrigge Predictors of symptoms are different from predictors of severe exacerbations from asthma in children Chest 140 2011 100 107
48. J. Marchini, and B. Howie Genotype imputation for genome-wide association studies Nat Rev Genet 11 2010 499 511
49. J.S. Halterman, K.M. McConnochie, K.M. Conn, H.L. Yoos, J.M. Kaczorowski, and R.J. Holzhauer et al. A potential pitfall in provider assessments of the quality of asthma control Ambul Pediatr 3 2003 102 105
50. J.E. Lang, and K.V. Blake Role of biomarkers in understanding and treating children with asthma: towards personalized care Pharmgenomics Pers Med 6 2013 73 84
51. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods Control Clin Trials 20 1999 91 120
52. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group Control Clin Trials 20 1999 91 120
53. S.J. Szefler, B.R. Phillips, F.D. Martinez, V.M. Chinchilli, R.F. Lemanske, and R.C. Strunk et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 115 2005 233 242
54. C.A. Sorkness, R.F. Lemanske Jr., D.T. Mauger, S.J. Boehmer, V.M. Chinchilli, and F.D. Martinez et al. Long-term comparison of 3 controller regimens for mildmoderate persistent childhood asthma: the Pediatric Asthma Controller trial J Allergy Clin Immunol 119 2007 64 72
55. S.C. Lazarus, H.A. Boushey, J.V. Fahy, V.M. Chinchilli, R.F. Lemanske Jr., and C.A. Sorkness et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
56. R.F. Lemanske Jr., C.A. Sorkness, E.A. Mauger, S.C. Lazarus, H.A. Boushey, and J.V. Fahy et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial JAMA 285 2001 2594 2603
57. R.J. Martin, S.J. Szefler, T.S. King, M. Kraft, H.A. Boushey, and V.M. Chinchilli et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial J Allergy Clin Immunol 119 2007 73 80
58. American Lung Association Asthma Clinical Research Centers, S.P. Peters, N. Anthonisen, M. Castro, J.T. Holbrook, and C.G. Irvin et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma N Engl J Med 356 2007 2027 2039
59. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods Control Clin Trials 20 1999 91 120
60. T.W. Guilbert, W.J. Morgan, M. Krawiec, R.F. Lemanske Jr., C. Sorkness, and S.J. Szefler et al. The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network Control Clin Trials 25 2004 286 310
61. B.E. Himes, G.M. Hunninghake, J.W. Baurley, N.M. Rafaels, P. Sleiman, and D.P. Strachan et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene Am J Hum Genet 84 2009 581 593
62. A.L. Price, N.J. Patterson, R.M. Plenge, M.E. Weinblatt, N.A. Shadick, and D. Reich Principal components analysis corrects for stratification in genome-wide association studies Nat Genet 38 2006 904 909
63. K.G. Tantisira, J. Lasky-Su, M. Harada, A. Murphy, A.A. Litonjua, and B.E. Himes et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma N Engl J Med 365 2011 1173 1183